U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07369050) titled 'A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses' on Jan. 23.
Brief Summary: The goal of this clinical research study is to learn if regular use of Provox(R) ActiValve(R) by patients after a total laryngectomy with TEP can decrease the number of VP device replacements needed annually.
Study Start Date: July 01, 2026
Study Type: INTERVENTIONAL
Condition:
Laryngectomy
Intervention:
DEVICE: Provox(R) ActiValve(R)
Participants experiencing early leakage with previous voice prostheses (device life less than 4-8 weeks). The device reduced the need for frequent replacements in a majority of user...